Annual report

Period2025-07-01 → 2026-06-30
Filed2026-09-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 144
MetricValuePeriodScopeSource row
Revenue¥3.9bn2025-07-01 → 2026-06-30Cons.Net sales
Revenue¥4.8bn2024-07-01 → 2025-06-30Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30vCons.Net sales (5-year summary)
Revenue¥8.1bn2022-07-01 → 2023-06-30vCons.Net sales (5-year summary)
Revenue¥9.3bn2021-07-01 → 2022-06-30vCons.Net sales (5-year summary)
Operating income¥276m2025-07-01 → 2026-06-30Cons.Operating income
Operating income−¥138m2024-07-01 → 2025-06-30Cons.Operating income
Ordinary income¥288m2025-07-01 → 2026-06-30Cons.Ordinary income
Ordinary income−¥129m2024-07-01 → 2025-06-30Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥727m2022-07-01 → 2023-06-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2021-07-01 → 2022-06-30vCons.Ordinary income loss (5-year summary)
Profit before tax¥230m2025-07-01 → 2026-06-30Cons.Income before income taxes
Profit before tax−¥220m2024-07-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥212m2025-07-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥211m2024-07-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥452m2022-07-01 → 2023-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥810m2021-07-01 → 2022-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥212m2025-07-01 → 2026-06-30Cons.Profit loss
Net income−¥211m2024-07-01 → 2025-06-30Cons.Profit loss
Total assets¥6.9bnat 2026-06-30Cons.Assets
Total assets¥6.8bnat 2025-06-30Cons.Assets
Total assets¥6.9bnat 2024-06-30vCons.Total assets (5-year summary)
Total assets¥8.2bnat 2023-06-30vCons.Total assets (5-year summary)
Total assets¥8.5bnat 2022-06-30vCons.Total assets (5-year summary)
Total liabilities¥742mat 2026-06-30Cons.Liabilities
Total liabilities¥775mat 2025-06-30Cons.Liabilities
Net assets / equity¥6.1bnat 2026-06-30Cons.Net assets
Net assets / equity¥6.0bnat 2025-06-30Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30vCons.Net assets
Net assets / equity¥7.2bnat 2023-06-30vCons.Net assets (5-year summary)
Net assets / equity¥6.8bnat 2022-06-30vCons.Net assets (5-year summary)
Cash and deposits¥5.4bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥5.0bnat 2025-06-30Cons.Cash and deposits
Cash & equivalents¥5.4bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30vCons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥6.0bnat 2022-06-30vCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥415m2025-07-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥558m2024-07-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥102m2022-07-01 → 2023-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥119m2025-07-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥389m2024-07-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥160m2022-07-01 → 2023-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥245m2021-07-01 → 2022-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥140m2025-07-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥214,0002024-07-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2022-07-01 → 2023-06-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2021-07-01 → 2022-06-30vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥8.122025-07-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.052024-07-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30vCons.Basic earnings loss per share (5-year summary)
Net assets per share¥233.56at 2026-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥230.22at 2025-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥238.28at 2024-06-30vCons.Net assets per share (5-year summary)
Net assets per share¥266.41at 2023-06-30vCons.Net assets per share (5-year summary)
Net assets per share¥254.14at 2022-06-30vCons.Net assets per share (5-year summary)
Equity ratio89.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30vCons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30vCons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30vCons.Equity to asset ratio (5-year summary)
ROE3.5%2025-07-01 → 2026-06-30Cons.Rate of return on equity (5-year summary)
ROE6.6%2022-07-01 → 2023-06-30vCons.Rate of return on equity (5-year summary)
ROE12.8%2021-07-01 → 2022-06-30vCons.Rate of return on equity (5-year summary)
Employees45at 2026-06-30Cons.Number of employees
Employees81at 2025-06-30Cons.Number of employees
Employees90at 2024-06-30vCons.Number of employees
Employees98at 2023-06-30vCons.Number of employees
Employees100at 2022-06-30vCons.Number of employees
Revenue¥838m2025-07-01 → 2026-06-30StandaloneNet sales
Revenue¥753m2024-07-01 → 2025-06-30StandaloneNet sales
Revenue¥304m2023-07-01 → 2024-06-30vStandaloneNet sales (5-year summary)
Revenue¥377m2022-07-01 → 2023-06-30vStandaloneNet sales (5-year summary)
Revenue¥439m2021-07-01 → 2022-06-30vStandaloneNet sales (5-year summary)
Operating income¥528m2025-07-01 → 2026-06-30StandaloneOperating income
Operating income¥409m2024-07-01 → 2025-06-30StandaloneOperating income
Ordinary income¥538m2025-07-01 → 2026-06-30StandaloneOrdinary income
Ordinary income¥420m2024-07-01 → 2025-06-30StandaloneOrdinary income
Ordinary income¥2m2023-07-01 → 2024-06-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥87m2022-07-01 → 2023-06-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥137m2021-07-01 → 2022-06-30vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥262m2025-07-01 → 2026-06-30StandaloneIncome before income taxes
Profit before tax¥388m2024-07-01 → 2025-06-30StandaloneIncome before income taxes
Net income¥334m2025-07-01 → 2026-06-30StandaloneProfit loss
Net income¥448m2024-07-01 → 2025-06-30StandaloneProfit loss
Net income−¥10m2023-07-01 → 2024-06-30vStandaloneNet income loss (5-year summary)
Net income¥142m2022-07-01 → 2023-06-30vStandaloneNet income loss (5-year summary)
Net income¥195m2021-07-01 → 2022-06-30vStandaloneNet income loss (5-year summary)
Total assets¥4.9bnat 2026-06-30StandaloneAssets
Total assets¥4.7bnat 2025-06-30StandaloneAssets
Total assets¥4.2bnat 2024-06-30vStandaloneTotal assets (5-year summary)
Total assets¥4.3bnat 2023-06-30vStandaloneTotal assets (5-year summary)
Total assets¥4.5bnat 2022-06-30vStandaloneTotal assets (5-year summary)
Total liabilities¥62mat 2026-06-30StandaloneLiabilities
Total liabilities¥59mat 2025-06-30StandaloneLiabilities
Net assets / equity¥4.8bnat 2026-06-30StandaloneNet assets
Net assets / equity¥4.6bnat 2025-06-30StandaloneNet assets
Net assets / equity¥4.1bnat 2024-06-30vStandaloneNet assets
Net assets / equity¥4.3bnat 2023-06-30vStandaloneNet assets (5-year summary)
Net assets / equity¥4.3bnat 2022-06-30vStandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2026-06-30StandaloneCash and deposits
Cash and deposits¥2.4bnat 2025-06-30StandaloneCash and deposits
EPS (basic)¥12.762025-07-01 → 2026-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.112024-07-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.42023-07-01 → 2024-06-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.442022-07-01 → 2023-06-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥7.472021-07-01 → 2022-06-30vStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥102025-07-01 → 2026-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52024-07-01 → 2025-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52022-07-01 → 2023-06-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥52021-07-01 → 2022-06-30vStandaloneDividend paid per share (5-year summary)
Net assets per share¥183.43at 2026-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥175.67at 2025-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥158.55at 2024-06-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥163.95at 2023-06-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥163.52at 2022-06-30vStandaloneNet assets per share (5-year summary)
Equity ratio98.7%at 2026-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio98.7%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.3%at 2024-06-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2023-06-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.6%at 2022-06-30vStandaloneEquity to asset ratio (5-year summary)
ROE7.1%2025-07-01 → 2026-06-30StandaloneRate of return on equity (5-year summary)
ROE10.2%2024-07-01 → 2025-06-30StandaloneRate of return on equity (5-year summary)
ROE3.3%2022-07-01 → 2023-06-30vStandaloneRate of return on equity (5-year summary)
ROE4.6%2021-07-01 → 2022-06-30vStandaloneRate of return on equity (5-year summary)
Shares issued26,158,200at 2026-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2024-06-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2023-06-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2022-06-30vStandaloneTotal number of issued shares (5-year summary)
Employees7at 2026-06-30StandaloneNumber of employees
Employees9at 2025-06-30StandaloneNumber of employees
Employees11at 2024-06-30vStandaloneNumber of employees
Employees7at 2023-06-30vStandaloneNumber of employees
Employees9at 2022-06-30vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 94
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2025-07-01 → 2026-06-30¥355,000
Reconciling Itemsreconcilingdepreciation2025-07-01 → 2026-06-30¥419,000
Reconciling Itemsreconcilingrevenue2025-07-01 → 2026-06-30−¥52m
Reconciling Itemsreconcilingrevenue external2025-07-01 → 2026-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2025-07-01 → 2026-06-30−¥53m
Reconciling Itemsreconcilingsegment assetsat 2026-06-30¥3.2bn
Reconciling Itemsreconcilingsegment profit2025-07-01 → 2026-06-30−¥309m
Clinical Evidence Servicereportable segmentcapex2025-07-01 → 2026-06-30¥316,000
Clinical Evidence Servicereportable segmentdepreciation2025-07-01 → 2026-06-30¥112,000
Clinical Evidence Servicereportable segmentemployeesat 2026-06-309 pure
Clinical Evidence Servicereportable segmentrevenue2025-07-01 → 2026-06-30¥215m
Clinical Evidence Servicereportable segmentrevenue external2025-07-01 → 2026-06-30¥215m
Clinical Evidence Servicereportable segmentsegment assetsat 2026-06-30¥324m
Clinical Evidence Servicereportable segmentsegment profit2025-07-01 → 2026-06-30¥15m
Functional Cosmetic Retailingreportable segmentemployeesat 2026-06-301 pure
Functional Cosmetic Retailingreportable segmentrevenue2025-07-01 → 2026-06-30¥907m
Functional Cosmetic Retailingreportable segmentrevenue external2025-07-01 → 2026-06-30¥883m
Functional Cosmetic Retailingreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥24m
Functional Cosmetic Retailingreportable segmentsegment assetsat 2026-06-30¥142m
Functional Cosmetic Retailingreportable segmentsegment profit2025-07-01 → 2026-06-30¥48m
Functional Food Retailingreportable segmentcapex2025-07-01 → 2026-06-30¥362,000
Functional Food Retailingreportable segmentdepreciation2025-07-01 → 2026-06-30¥8m
Functional Food Retailingreportable segmentemployeesat 2026-06-3013 pure
Functional Food Retailingreportable segmentrevenue2025-07-01 → 2026-06-30¥1.7bn
Functional Food Retailingreportable segmentrevenue external2025-07-01 → 2026-06-30¥1.7bn
Functional Food Retailingreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥15m
Functional Food Retailingreportable segmentsegment assetsat 2026-06-30¥2.4bn
Functional Food Retailingreportable segmentsegment profit2025-07-01 → 2026-06-30¥329m
Functional Material Developmentreportable segmentdepreciation2025-07-01 → 2026-06-30¥44,000
Functional Material Developmentreportable segmentemployeesat 2026-06-301 pure
Functional Material Developmentreportable segmentrevenue2025-07-01 → 2026-06-30¥311m
Functional Material Developmentreportable segmentrevenue external2025-07-01 → 2026-06-30¥297m
Functional Material Developmentreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥14m
Functional Material Developmentreportable segmentsegment assetsat 2026-06-30¥277m
Functional Material Developmentreportable segmentsegment profit2025-07-01 → 2026-06-30¥33m
Health Care Support Servicereportable segmentcapex2025-07-01 → 2026-06-30¥37m
Health Care Support Servicereportable segmentdepreciation2025-07-01 → 2026-06-30¥4m
Health Care Support Servicereportable segmentemployeesat 2026-06-3014 pure
Health Care Support Servicereportable segmentrevenue2025-07-01 → 2026-06-30¥787m
Health Care Support Servicereportable segmentrevenue external2025-07-01 → 2026-06-30¥787m
Health Care Support Servicereportable segmentsegment assetsat 2026-06-30¥451m
Health Care Support Servicereportable segmentsegment profit2025-07-01 → 2026-06-30¥160m
—segment totalcapex2025-07-01 → 2026-06-30¥37m
—segment totaldepreciation2025-07-01 → 2026-06-30¥13m
—segment totalrevenue2025-07-01 → 2026-06-30¥3.9bn
—segment totalrevenue external2025-07-01 → 2026-06-30¥3.9bn
—segment totalrevenue intersegment2025-07-01 → 2026-06-30¥53m
—segment totalsegment assetsat 2026-06-30¥3.6bn
—segment totalsegment profit2025-07-01 → 2026-06-30¥585m
Reconciling Itemsreconcilingcapex2024-07-01 → 2025-06-30¥548,000
Reconciling Itemsreconcilingdepreciation2024-07-01 → 2025-06-30¥557,000
Reconciling Itemsreconcilingrevenue2024-07-01 → 2025-06-30−¥26m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2025-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2025-06-30−¥28m
Reconciling Itemsreconcilingsegment assetsat 2025-06-30¥2.8bn
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2025-06-30−¥343m
Clinical Evidence Servicereportable segmentcapex2024-07-01 → 2025-06-30¥4m
Clinical Evidence Servicereportable segmentdepreciation2024-07-01 → 2025-06-30¥6m
Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2025-06-30¥242m
Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2025-06-30¥242m
Clinical Evidence Servicereportable segmentsegment assetsat 2025-06-30¥321m
Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2025-06-30¥9m
Functional Cosmetic Retailingreportable segmentcapex2024-07-01 → 2025-06-30¥30m
Functional Cosmetic Retailingreportable segmentdepreciation2024-07-01 → 2025-06-30¥2m
Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2025-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2025-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2025-06-30¥745m
Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2025-06-30¥27m
Functional Food Retailingreportable segmentcapex2024-07-01 → 2025-06-30¥357,000
Functional Food Retailingreportable segmentdepreciation2024-07-01 → 2025-06-30¥8m
Functional Food Retailingreportable segmentrevenue2024-07-01 → 2025-06-30¥2.1bn
Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2025-06-30¥2.1bn
Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2025-06-30¥13m
Functional Food Retailingreportable segmentsegment assetsat 2025-06-30¥1.1bn
Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2025-06-30¥91m
Functional Material Developmentreportable segmentdepreciation2024-07-01 → 2025-06-30¥297,000
Functional Material Developmentreportable segmentrevenue2024-07-01 → 2025-06-30¥298m
Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2025-06-30¥283m
Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2025-06-30¥15m
Functional Material Developmentreportable segmentsegment assetsat 2025-06-30¥1.3bn
Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2025-06-30−¥28m
Health Care Support Servicereportable segmentcapex2024-07-01 → 2025-06-30¥3m
Health Care Support Servicereportable segmentdepreciation2024-07-01 → 2025-06-30¥1m
Health Care Support Servicereportable segmentrevenue2024-07-01 → 2025-06-30¥688m
Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2025-06-30¥688m
Health Care Support Servicereportable segmentsegment assetsat 2025-06-30¥528m
Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2025-06-30¥107m
—segment totalcapex2024-07-01 → 2025-06-30¥37m
—segment totaldepreciation2024-07-01 → 2025-06-30¥18m
—segment totalrevenue2024-07-01 → 2025-06-30¥4.9bn
—segment totalrevenue external2024-07-01 → 2025-06-30¥4.8bn
—segment totalrevenue intersegment2024-07-01 → 2025-06-30¥28m
—segment totalsegment assetsat 2025-06-30¥4.0bn
—segment totalsegment profit2024-07-01 → 2025-06-30¥205m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,295
ItemContextValueUnit
Machinery and equipment netCurrentYearInstant0JPY
Tools furniture and fixturesPrior1YearInstant119149000JPY
Tools furniture and fixturesCurrentYearInstant107508000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-115535000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant-102649000JPY
Tools furniture and fixtures netPrior1YearInstant3614000JPY
Tools furniture and fixtures netCurrentYearInstant4859000JPY
Property plant and equipmentPrior1YearInstant9601000JPY
Property plant and equipmentCurrentYearInstant40814000JPY
Other iaPrior1YearInstant18962000JPY
Other iaCurrentYearInstant11970000JPY
Intangible assetsPrior1YearInstant18962000JPY
Intangible assetsCurrentYearInstant11970000JPY
Investment securitiesPrior1YearInstant26351000JPY
Investment securitiesCurrentYearInstant25000000JPY
Deferred tax assetsPrior1YearInstant29848000JPY
Deferred tax assetsCurrentYearInstant51411000JPY
Other ioaPrior1YearInstant130832000JPY
Other ioaCurrentYearInstant58963000JPY
Investments and other assetsPrior1YearInstant187032000JPY
Investments and other assetsCurrentYearInstant135374000JPY
Noncurrent assetsPrior1YearInstant215596000JPY
Noncurrent assetsCurrentYearInstant188159000JPY
AssetsPrior1YearInstant6812899000JPY
AssetsCurrentYearInstant6851930000JPY
Accounts payable tradePrior1YearInstant191051000JPY
Accounts payable tradeCurrentYearInstant35906000JPY
Income taxes payablePrior1YearInstant22876000JPY
Income taxes payableCurrentYearInstant47665000JPY
Provision for shareholder benefit program clPrior1YearInstant25471000JPY
Provision for shareholder benefit program clCurrentYearInstant4027000JPY
Contract liabilitiesPrior1YearInstant326937000JPY
Contract liabilitiesCurrentYearInstant473687000JPY
Other clPrior1YearInstant189857000JPY
Other clCurrentYearInstant181190000JPY
Current liabilitiesPrior1YearInstant756194000JPY
Current liabilitiesCurrentYearInstant742476000JPY
Net defined benefit liabilityPrior1YearInstant18962000JPY
Net defined benefit liabilityCurrentYearInstant-JPY
Noncurrent liabilitiesPrior1YearInstant18962000JPY
Noncurrent liabilitiesCurrentYearInstant-JPY
LiabilitiesPrior1YearInstant775157000JPY
LiabilitiesCurrentYearInstant742476000JPY
Capital stockPrior1YearInstant1836587000JPY
Capital stockCurrentYearInstant1836587000JPY
Capital surplusPrior1YearInstant1956966000JPY
Capital surplusCurrentYearInstant1962747000JPY
Retained earningsPrior1YearInstant2228621000JPY
Retained earningsCurrentYearInstant2310120000JPY
Treasury stockPrior1YearInstant-0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2025-06-30pass rounding
balance sheet identityconsolidated 2026-06-30pass
balance sheet identitynon_consolidated 2025-06-30pass
balance sheet identitynon_consolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · net assetsnon_consolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-07-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2025-07-01/2026-06-30pass
statement vs summary · revenueconsolidated 2024-07-01/2025-06-30pass
statement vs summary · revenueconsolidated 2025-07-01/2026-06-30pass
statement vs summary · revenuenon_consolidated 2024-07-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2025-07-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-06-30pass
statement vs summary · total assetsconsolidated 2026-06-30pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass
statement vs summary · total assetsnon_consolidated 2026-06-30pass